By Katy Barnato
Hims & Hers Health (HERS): The telehealth company said it would stop offering compounded semaglutide, the active ingredient in weight-loss drugs Wegovy and Ozempic, after the first quarter. Hims shares dropped roughly 16% in premarket trading.
Zoom Communications (ZM): Shares fell 3% ahead of the opening bell after revenue guidance from the video-conferencing company disappointed investors.
Solventum (SOLV): Thermo Fisher Scientific $(TMO)$ is nearing a deal to buy the healthcare company's purification and filtration business. A transaction is expected to value the unit between $3.5 billion and $4 billion. Solventum was spun off from 3M last year.
Coinbase $(COIN)$, Strategy $(MSTR.AU)$ and Robinhood (HOOD): Crypto-sensitive stocks fell premarket, as bitcoin prices dropped below $90,000. Strategy, formerly known as MicroStrategy, said late Monday that it had recently bought more bitcoin.
Cleveland-Cliffs $(CLF)$: The steel maker widened its loss and logged lower sales last quarter. Chief Executive Lourenco Goncalves forecast a rebound in 2025, boosted by President Trump's policies. But shares fell roughly 4.5% premarket.
Home Depot $(HD)$ and Keurig Dr. Pepper $(KDP)$ are set to report earnings before the U.S. market opens.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
February 25, 2025 05:00 ET (10:00 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。